Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and Cell Therapy Program Awarded Accreditation by the Foundation for the Accreditation of Cellular Therapy
April 26, 2024
April 26, 2024
NEW BRUNSWICK, New Jersey, April 26 -- Rutgers Cancer Institute of New Jersey issued the following news:
The Foundation for the Accreditation of Cellular Therapy (FACT) has once again awarded Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's (RWJUH) Transplant and Cell Therapy Program accreditation under the FACT-JACIE International Standards for Hematopoietic Cellular Therapy.
The accreditation is effective for three years beginning A . . .
The Foundation for the Accreditation of Cellular Therapy (FACT) has once again awarded Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's (RWJUH) Transplant and Cell Therapy Program accreditation under the FACT-JACIE International Standards for Hematopoietic Cellular Therapy.
The accreditation is effective for three years beginning A . . .